COVID-19 vaccine effectiveness in patients with hematologic malignancy

Transpl Infect Dis. 2022 Dec;24(6):e13850. doi: 10.1111/tid.13850. Epub 2022 Aug 16.

Abstract

  1. COVID‐19 vaccine response → HM<solid

  2. Breakthrough infections → HM>solid

  3. Vaccine effectiveness → Population studies urgently needed

  4. Early #COVID19CP could be lifesaving in immunocompromised HM pts

This article is protected by copyright. All rights reserved

Keywords: SARS-CoV-2; blood cancer; breakthrough infections; leukemia; lymphoma; vaccine effectiveness.

Publication types

  • Editorial

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Hematologic Neoplasms* / complications
  • Humans
  • Vaccine Efficacy

Substances

  • COVID-19 Vaccines